ACTIVE

PHARMACIE HENRY

Financial year 2025 · Closed on 31/12/2025

Net result227,8 k €+45,0 %over 1 year
Gross margin899,1 k €+11,2 %over 1 year
Equity1,4 M €+14,1 %over 1 year
Workforce8,1 ETP+8,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE HENRY is a Public limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Pont-à-Celles. It employs on average 8,1 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0465.730.355
Incorporation
26/03/1999
Legal form
Public limited company
Registered office
Rue Roosevelt(LUT) 29
6238 Pont-à-Celles · WallonieSee on map
Contributed capital
62 500,00 €
Latest accounts
31/12/2025
Average workforce
8,1 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin899,1 k €808,8 k €828,3 k €796,7 k €654,5 k €
EBITDA423,1 k €337,1 k €359,6 k €380,6 k €278,5 k €
Operating result316,5 k €231,8 k €255,3 k €276,7 k €196,8 k €
Net result227,8 k €157 k €174 k €187,8 k €133,2 k €
Balance sheet
Equity1,4 M €1,2 M €1,1 M €942,4 k €754,6 k €
Total assets2,9 M €2,9 M €3 M €2,9 M €2,5 M €
Cash31,3 k €61,8 k €46,5 k €43,8 k €89,3 k €
Debts1,5 M €1,7 M €1,9 M €2 M €1,8 M €
Other
Workforce8,1 ETP7,5 ETP7,9 ETP9,1 ETP8,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 10 ended

Active mandates

HENRY PHARMA

Managing director · since 26 mai 2023 · until 25 mai 2029 · 0688.865.294

Represented by STEPHANE HENRY

Active

Ended mandates

HENRY PHARMA

Managing director · since 29 décembre 2017 · until 31 mai 2024 · 0688.865.294

Represented by STEPHANE HENRY

Ended
HENRY PHARMA

Managing director · since 29 décembre 2017 · until 31 mai 2024 · 0688.865.294

Represented by STEPHANE HENRY

Ended
OLIVIA DECKERS

Director · since 25 mai 2012 · until 29 décembre 2017

Ended
OLIVIA DECKERS

Director · since 25 mai 2012 · until 25 mai 2018

Ended

Other companies at this address

Rue Roosevelt(LUT) 29 6238 Pont-à-Celles
CompanyCBE no.
HENRY PHARMA● Active
0688.865.294

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/06/202607/08/202503/07/202428/06/202316/06/202223/06/2021
General meeting29/05/202630/05/202531/05/202426/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202601/06/2026FrenchPDF
Abridged model31/12/202430/05/202507/08/2025FrenchPDF
Abridged model31/12/202331/05/202403/07/2024FrenchPDF
Abridged model31/12/202226/05/202328/06/2023FrenchPDF
Abridged model31/12/202127/05/202216/06/2022FrenchPDF
Abridged model31/12/202028/05/202123/06/2021FrenchPDF
Abridged model31/12/201929/05/202005/06/2020FrenchPDF
Abridged model31/12/201831/05/201907/08/2019FrenchPDF
Abridged model31/12/201725/05/201816/07/2018FrenchPDF
Abridged model31/12/201626/05/201719/07/2017FrenchPDF
Abridged model31/12/201527/05/201627/07/2016FrenchPDF
Abridged model31/12/201429/05/201530/07/2015FrenchPDF
Abridged model31/12/201330/05/201409/07/2014FrenchPDF
Abridged model31/12/201231/05/201324/07/2013FrenchPDF
Abridged model31/12/201125/05/201230/08/2012FrenchPDF
Abridged model31/12/201027/05/201120/07/2011FrenchPDF
Abridged model31/12/200928/05/201011/06/2010FrenchPDF
Abridged model31/12/200829/05/200923/07/2009FrenchPDF
Abridged model31/12/200730/05/200829/09/2008FrenchPDF
Abridged modelCorrection31/12/200622/02/200816/05/2008FrenchPDF
Abridged model31/12/200625/05/200730/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 10 ended

Active mandates

HENRY PHARMA

Managing director · since 26 mai 2023 · until 25 mai 2029 · 0688.865.294

Represented by STEPHANE HENRY

Active

Ended mandates

HENRY PHARMA

Managing director · since 29 décembre 2017 · until 31 mai 2024 · 0688.865.294

Represented by STEPHANE HENRY

Ended
HENRY PHARMA

Managing director · since 29 décembre 2017 · until 31 mai 2024 · 0688.865.294

Represented by STEPHANE HENRY

Ended
OLIVIA DECKERS

Director · since 25 mai 2012 · until 29 décembre 2017

Ended
OLIVIA DECKERS

Director · since 25 mai 2012 · until 25 mai 2018

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates12/07/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/03/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/04/2013
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/03/2006
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates25/07/2005
    SIEGE SOCIAL - DENOMINATION
    PDF
  • Restructuring30/05/2005
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - CAPITAL, ACTIONS
    PDF
  • Restructuring22/02/2005
    DIVERS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025227,8 k €↑
  2. 2024
    Annual accounts 2024157 k €↓
  3. 2023
    Annual accounts 2023174 k €↓
  4. 2022
    Annual accounts 2022187,8 k €↑
  5. 2021
    Annual accounts 2021133,2 k €↓
  6. 2020
    Annual accounts 2020139,5 k €↑
  7. 2019
    Annual accounts 201965,5 k €↑
  8. 2018
    Annual accounts 201859,3 k €↓
  9. 2017
    Annual accounts 201791,6 k €↓
  10. 2016
    Annual accounts 2016165,9 k €↑
  11. 2015
    Annual accounts 2015115,6 k €↓
  12. 2014
    Annual accounts 2014117,1 k €↑
  13. 2013
    Annual accounts 201350,7 k €↑
  14. 2012
    Annual accounts 201246,7 k €↑
  15. 2011
    Annual accounts 201121,8 k €↓
  16. 2010
    Annual accounts 201025 k €↓
  17. 2009
    Annual accounts 200937,2 k €↑
  18. 2008
    Annual accounts 20082,8 k €↓
  19. 2007
    Annual accounts 20078 k €↑
  20. 2006
    Annual accounts 2006-31 k €
  21. 26/03/1999
    IncorporationPublic limited company